BDBM3185 (+-)-2-[[2,6-Dihydroxy-4-[[[3-(4-hydroxyphenyl)-2-[(phenylsulfonyl)amino]propyl]oxy]carbonyl]phenyl]carbonyl]-3-hydroxybenzoic Acid::2-[(4-{[2-benzenesulfonamido-3-(4-hydroxyphenyl)propoxy]carbonyl}-2,6-dihydroxyphenyl)carbonyl]-3-hydroxybenzoic acid::Acyclic Balanol Analog 6b

SMILES OC(=O)c1cccc(O)c1C(=O)c1c(O)cc(cc1O)C(=O)OCC(Cc1ccc(O)cc1)NS(=O)(=O)c1ccccc1

InChI Key InChIKey=PQWWKDOKHDWZBH-UHFFFAOYSA-N

Data  8 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 8 hits for monomerid = 3185   

TargetProtein kinase C alpha type(Human)
Sphinx Laboratories

LigandPNGBDBM3185((+-)-2-[[2,6-Dihydroxy-4-[[[3-(4-hydroxyphenyl)-2-...)
Affinity DataIC50: 110nMAssay Description:PKC was assayed by quantitating the incorporation of 32P from [gamma-32P]ATP into histone type IIIs.More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/31/2005
Entry Details Article
PubMed
TargetProtein kinase C beta type(Human)
Sphinx Laboratories

LigandPNGBDBM3185((+-)-2-[[2,6-Dihydroxy-4-[[[3-(4-hydroxyphenyl)-2-...)
Affinity DataIC50: 220nMAssay Description:PKC was assayed by quantitating the incorporation of 32P from [gamma-32P]ATP into histone type IIIs.More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/31/2005
Entry Details Article
PubMed
TargetProtein kinase C beta type(Human)
Sphinx Laboratories

LigandPNGBDBM3185((+-)-2-[[2,6-Dihydroxy-4-[[[3-(4-hydroxyphenyl)-2-...)
Affinity DataIC50: 30nMAssay Description:PKC was assayed by quantitating the incorporation of 32P from [gamma-32P]ATP into histone type IIIs.More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/31/2005
Entry Details Article
PubMed
TargetProtein kinase C gamma type(Human)
Sphinx Laboratories

LigandPNGBDBM3185((+-)-2-[[2,6-Dihydroxy-4-[[[3-(4-hydroxyphenyl)-2-...)
Affinity DataIC50: 220nMAssay Description:PKC was assayed by quantitating the incorporation of 32P from [gamma-32P]ATP into histone type IIIs.More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/31/2005
Entry Details Article
PubMed
TargetProtein kinase C delta type(Human)
Sphinx Laboratories

LigandPNGBDBM3185((+-)-2-[[2,6-Dihydroxy-4-[[[3-(4-hydroxyphenyl)-2-...)
Affinity DataIC50: 40nMAssay Description:PKC was assayed by quantitating the incorporation of 32P from [gamma-32P]ATP into histone type IIIs.More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/31/2005
Entry Details Article
PubMed
TargetProtein kinase C epsilon type(Human)
Sphinx Laboratories

LigandPNGBDBM3185((+-)-2-[[2,6-Dihydroxy-4-[[[3-(4-hydroxyphenyl)-2-...)
Affinity DataIC50: 320nMAssay Description:PKC was assayed by quantitating the incorporation of 32P from [gamma-32P]ATP into histone type IIIs.More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/31/2005
Entry Details Article
PubMed
TargetProtein kinase C eta type(Human)
Sphinx Laboratories

LigandPNGBDBM3185((+-)-2-[[2,6-Dihydroxy-4-[[[3-(4-hydroxyphenyl)-2-...)
Affinity DataIC50: 20nMAssay Description:PKC was assayed by quantitating the incorporation of 32P from [gamma-32P]ATP into histone type IIIs.More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/31/2005
Entry Details Article
PubMed
LigandPNGBDBM3185((+-)-2-[[2,6-Dihydroxy-4-[[[3-(4-hydroxyphenyl)-2-...)
Affinity DataIC50: 5.00E+4nMAssay Description:The activity of PKA, activated by cAMP, is measured by its ability to transfer phosphate from [gamma-32P]ATP to histone.More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/31/2005
Entry Details Article
PubMed